Cheng Luo

18.8k total citations · 4 hit papers
457 papers, 12.7k citations indexed

About

Cheng Luo is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Cheng Luo has authored 457 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 300 papers in Molecular Biology, 60 papers in Oncology and 39 papers in Organic Chemistry. Recurrent topics in Cheng Luo's work include Epigenetics and DNA Methylation (67 papers), Cancer-related gene regulation (52 papers) and Protein Degradation and Inhibitors (49 papers). Cheng Luo is often cited by papers focused on Epigenetics and DNA Methylation (67 papers), Cancer-related gene regulation (52 papers) and Protein Degradation and Inhibitors (49 papers). Cheng Luo collaborates with scholars based in China, United States and Germany. Cheng Luo's co-authors include Hualiang Jiang, Sarah Spiegel, Nitai C. Hait, Zhongjie Liang, Jeremy C. Allegood, Sheldon Milstien, Kaixian Chen, Junyan Lu, Mingyue Zheng and Tomasz Kordula and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Cheng Luo

445 papers receiving 12.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate

2009 802 citations Nitai C. Hait, Jeremy C. Allegood et al. Science profile →
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2

2010 615 citations Kuzhuvelil B. Harikumar, Nitai C. Hait et al. profile →
Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5

2014 555 citations Hualiang Jiang, Cheng Luo et al. profile →
Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1

2023 109 citations Cheng Luo, Hao Zhang et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheng Luo China	51	8.4k	1.4k	1.3k	1.2k	988	457	12.7k
Anton Simeonov United States	65	8.4k 1.0×	1.5k 1.0×	1.5k 1.2×	835 0.7×	2.4k 2.4×	298	14.1k
Robert A. Copeland United States	44	7.6k 0.9×	1.4k 1.0×	1.8k 1.4×	840 0.7×	1.2k 1.2×	165	11.9k
Duxin Sun United States	61	8.3k 1.0×	1.4k 1.0×	3.3k 2.6×	1.7k 1.5×	782 0.8×	281	14.9k
Wei Li China	57	8.0k 1.0×	1.1k 0.8×	1.0k 0.8×	1.2k 1.0×	447 0.5×	750	15.7k
Chu Wang China	43	6.4k 0.8×	2.1k 1.4×	1.1k 0.8×	599 0.5×	602 0.6×	245	9.8k
Christopher P. Austin United States	59	5.7k 0.7×	973 0.7×	962 0.8×	884 0.8×	2.5k 2.5×	172	11.9k
Katja Becker Germany	57	7.0k 0.8×	1.5k 1.0×	1.2k 0.9×	387 0.3×	527 0.5×	223	12.7k
Ajit Jadhav United States	50	5.1k 0.6×	929 0.6×	1.0k 0.8×	543 0.5×	1.3k 1.3×	150	8.1k
Xiang Chen China	48	6.3k 0.7×	634 0.4×	1.7k 1.3×	1.7k 1.4×	756 0.8×	391	12.3k
John S. Lazo United States	61	7.9k 0.9×	1.5k 1.0×	2.9k 2.3×	1.4k 1.2×	432 0.4×	323	13.5k

Countries citing papers authored by Cheng Luo

Since Specialization

Citations

This map shows the geographic impact of Cheng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Luo more than expected).

Fields of papers citing papers by Cheng Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Luo. The network helps show where Cheng Luo may publish in the future.

Co-authorship network of co-authors of Cheng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Luo. A scholar is included among the top collaborators of Cheng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Luo. Cheng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Chang‐Han, Weiping Liu, Zhixiang Zhao, et al.. (2025). Longevity Humans Have Youthful Erythrocyte Function and Metabolic Signatures. Aging Cell. 24(5). e14482–e14482. 5 indexed citations

Dong, Yan, et al.. (2024). Enzyme-free and rapid colorimetric analysis of osteopontin via triple-helix aptamer probe coupled with catalytic hairpin assembly reaction. Analytica Chimica Acta. 1312. 342764–342764. 3 indexed citations

Luo, Lingfeng, et al.. (2024). Modeling of multi-phase flow in plasma transferred arc cladding of NiCrBSi/WC metal matrix composite. International Journal of Heat and Mass Transfer. 232. 125944–125944. 4 indexed citations

Ye, Xu, et al.. (2024). Discovery of SET domain-binding primary alkylamine-tethered degraders for the simultaneous degradation of NSD2-long and RE-IIBP isoforms. European Journal of Medicinal Chemistry. 283. 117179–117179. 2 indexed citations

He, Yang, Zhigang Wang, Cheng Luo, et al.. (2024). Deciphering the coupling of anoxic/aerobic and sulfur autotrophic denitrification: Performance, antibiotic resistance genes, and microbial community structure. Journal of environmental chemical engineering. 13(1). 115289–115289. 2 indexed citations

Wang, Zhen, Zhihai Li, Fei Ye, et al.. (2024). Structural insights into the functional mechanism of the ubiquitin ligase E6AP. Nature Communications. 15(1). 3531–3531. 14 indexed citations

Qian, Hui, Chen‐Hong Ding, Fang Liu, et al.. (2024). SRY-Box transcription factor 9 triggers YAP nuclear entry via direct interaction in tumors. Signal Transduction and Targeted Therapy. 9(1). 96–96. 8 indexed citations

Meng, Jun, Cheng Luo, Changchun Li, et al.. (2023). Study on baking deformation of the thin-walled arc chamber. Vacuum. 210. 111856–111856. 2 indexed citations

Luo, Cheng, Jun Meng, Jiancheng Yang, et al.. (2023). Study on the performance of titanium alloy-lined thin-walled vacuum chamber. Vacuum. 221. 112808–112808. 3 indexed citations

10.

Zhang, Bei, Siqi Wang, Ye Lü, et al.. (2023). OTTM: an automated classification tool for translational drug discovery from omics data. Briefings in Bioinformatics. 24(5). 1 indexed citations

11.

Luo, Cheng, et al.. (2023). Microalgae-mediated tandem culture of shrimp and bivalve: an environmental and health co-benefits solution for phosphorus recovery and emission reduction. Frontiers in Marine Science. 10. 1 indexed citations

12.

Fan, Shijie, Wei Wan, Pan Xu, et al.. (2023). An ATG4B inhibitor blocks autophagy and sensitizes Sorafenib inhibition activities in HCC tumor cells. Bioorganic & Medicinal Chemistry. 84. 117262–117262. 13 indexed citations

13.

Luo, Cheng, et al.. (2021). MicroRNA-130b-5p accelerates the migration and invasion of osteosarcoma via binding to TIMP2. SHILAP Revista de lepidopterología.

14.

Luo, Cheng, Yi Shen, Yang Liu, & Zhenhui Jiang. (2019). Look and Feel: The Importance of Sensory Feedback in Virtual Product Experience. Journal of the Association for Information Systems. 3 indexed citations

15.

Li, Jiacheng, Jing Huang, Pan Xu, et al.. (2019). p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization. Theranostics. 9(26). 8344–8361. 73 indexed citations

16.

Gao, Zhen, Dan Zhao, Lunfeng Zhang, et al.. (2017). PI-273, a Substrate-Competitive, Specific Small-Molecule Inhibitor of PI4KIIα, Inhibits the Growth of Breast Cancer Cells. Cancer Research. 77(22). 6253–6266. 36 indexed citations

17.

Lu, Wenchao, Hao Jiang, Zhengbing Lv, et al.. (2017). Discovery of alkyl bis(oxy)dibenzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors. Chemical Biology & Drug Design. 90(6). 1260–1270. 10 indexed citations

18.

Ye, Fei, Wenchao Lu, Yiqian Xie, et al.. (2016). Identification of Novel Inhibitors against Coactivator Associated Arginine Methyltransferase 1 Based on Virtual Screening and Biological Assays. BioMed Research International. 2016. 1–8. 10 indexed citations

19.

Sun, Wenyi, Zuoquan Xie, Yifu Liu, et al.. (2015). JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification. Cancer Research. 75(22). 4923–4936. 69 indexed citations

20.

Hait, Nitai C., Jeremy C. Allegood, Michael Maceyka, et al.. (2009). Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate. Science. 325(5945). 1254–1257. 802 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact